Issue
Title
Authors
Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes
Ostroumova O.D., Surkova E.V., Goloborodova I.V., Starodubova A.V., Kochetkov A.I., Kiknadze T.D., Galstyan G.R.
Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences
Haahr H., Heise T.
Meeting of the expert committee on the use of pre-mixed insulin preparation Humalog Mix 50 in type 2 diabetes mellitus
Diabetes Mellitus E.
Lantus (Insulin Glargin): new insulin on Russian market
Diabetes Mellitus E.
Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
Dedov I.I., Shestakova M.V.
Analogi insulina (insulin detemir i insulin aspart) v sravnenii s traditsionnymi chelovecheskimi insulinami (NPKh-insulinom i chelovecheskim insulinom korotkogo deystviya) v bazal'no-bolyusnoy terapii bol'nykh sakharnym diabetom 1 tipa
Khermansen K., Fonten P., Kukolyya K.K., Peterkova V.A., Leyt G., Gall M.
Sravnenie kombinatsiy insulina lizpromiks 25 s metforminom i insulina glarginas metforminom pri lechenii patsientovs sakharnym diabetom 2 tipa,ranee ne poluchavshikh insulinoterapii(16-nedel'noe randomizirovannoe otkrytoeperekrestnoe issledovanie)
Malone J.K., Kerr L.E., Campaigne B.N., Sachson R.A., Holcombe J.H.
Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
Yarek-Martynova I.R., Bolotskaya L.L.
Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
Klimontov V.V., Lazarev M.M., Letyagin A.J., Bulumbaeva D.M., Bgatova N.P.
Biopharmaceuticals. Official position of Russian Association of Endocrinologists
Diabetes Mellitus E.
The works of professor N.P. Kravkov in the area of endocrinology
Uzbekova D.G.
Biosimilars: presumption of guilt
Shestakova M.V., Vikulova O.K.
Diabetes mellitus and other pathology in patients with INS and INSR mutations
Pankov Y.A.
Insulin resistance: the conflict between biological settings of energy metabolism and human lifestyle (a glance at the problem from evolutionary viewpoint)
Titov V.N., Shirinsky V.P.
Effective and safe control of glycemia with insulin Apidra - the recipe for success of type 2 diabetes prophylaxis
Biryukova E.V.
Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
Antsiferov M.B., Galstyan G.R., Zilov A.V., Mayorov A.Y., Markova T.N., Demidov N.A., Koteshkova O.M., Laptev D.N., Vitebskaya A.V.
Immunohystochemical study of the largest islets of human pancreas in aging and diabetes mellitus: perspectives for the transplantation
Proshchina A.E., Krivova Y.S., Barabanov V.M., Savelyev S.V.
The injection technique: results of a questionnaire study of diabetic patients in Russia. New international guidelines on the injectiontechnique
Mel'nikova O.G., Mayorov A.Y.
Pathogenetic significance of single nucleotide polymorphisms in the gastric inhibitory polypeptide receptor gene for the development of carbohydrate metabolism disorders in obesity
Skuratovskaia D.S., Vasilenko M.A., Fattakhov N.S., Kirienkova E.V., Mironyuk N.I., Zatolokin P.A., Litvinova L.S.
Harold Himsworth, founder of diabetes classification: 105th anniversary of his birthday
Fedorova O.S.
Hyperglycaemia in criticaly ill patients
Klypa T.V., Orehova M.S., Zabrosaeva L.I.
Ispol'zovanie ul'trakorotkogo analoga insulina Lizpro u beremennykh s sakharnym diabetom
Ragozin A.K.
Mauriac syndrome in adult with type 1 diabetes mellitus
Molitvoslovova N.A., Tokmakova A.Y.
Geneticheskie markery i funktsiya (beta-kletok v rannikh (doklinicheskikh) stadiyakh sakharnogo diabeta tipa 1
Kuraeva T.L., Titovich E.V., Kolesnikova G.S., Peterkova V.A.
Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice
Suplotova L.A., Plotnikov N.V., Romanova N.V., Bel’chikova L.N., Khieva E.V., Shestakova M.V.
Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. & Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506)
Shestakova M.V., Glinkina I.V.
Insulin/weight ratio may serve as a predictor of success during insulin pump therapy in type 2 diabetes patients: a proof-of-concept study
Levit S., Filippov Y.I., Cohen O., Weichman M., Azuri J., Manisteski Y., Levit V.M.
Otsenka klinicheskogo primeneniya Lantusa (insulina glargin) v praktike raboty endokrinologicheskoy sluzhby Moskvy
Antsiferov M.B., Dorofeeva L.G.
The role of Leu260Phe polymorphism of the receptor gene to GLP-1 incretin in the pathogenesis of diabetes type 2 diabetes with obesity
Skuratovskaia D.A., Vulf M.A., Kirienkova E.V., Myronyuk N.I., Zatolokin P.A., Litvinova L.S.
Sakharnyy diabet v Rossiyskoy Federatsii: problemy i puti resheniya
Dedov I.I.
On the safety of insulin Glargine
Dedov I.I., Shestakova, M.V., Peterkova V.A.
Opyt primeneniya analoga chelovecheskogo insulina Shch1'trakorotkogo deystviya Novo Rapid' (Aspart) u detey
Peterkova V., Kuraeva T., Andrianova E., Shcherbacheva Y., Maksimova V., Titovich E.
Age-related hypogonadism in men with metabolic syndrome
Tishova Y.A., Mskhalaya G.Z., Kalinchenko S.Y.
Hormonal, electrolyte disturbances and features of hemostasis in term newborn infants of mothers with gestational diabetes mellitus.
Mikhalev E.V., Shanina O.M., Saprina T.V.
Apidra (insulin glulizin) v terapii sakharnogo diabeta 1 tipa
Pavlova M.G.
Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clamp method on healthy volonters
Mayorov A.Y., Koksharova E.O., Mishina E.E., Drai R.V., Avdeeva O.I., Makarenko I.E.
Diabeticheskiy ketoatsidoz u detey
Martynova M.I., Rodionova E.M., Pilyutik V.F.
Can simple intensification of therapy with modern two-phase insulin help in type 2 diabetes when target glycemia failed to be achieved withbasal insulin? Results of subanalysis in the PRESENT study
Yang C.S., Guler S., Shestakova M.V.
A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus
Shestakova M.V., Elizarova S.V., Jabbar A.
Effektivnost' i bezopasnost' dvukhfaznogo insulina Aspart 30 po dannym lecheniya patsientov s sakharnym diabetom 2 tipa v Rossiyskoy Federatsii: rezul'taty mnogotsentrovogo nablyudatel'nogo issledovaniya
Shestakova M.V., Lebedev N., Zhin Ping E.
National advisory board on diabetes mellitus: unsolved issues and new opportunities for diabetes treatment
Galstyan G.R.
Poslednie dostizheniya i perspektivy profilaktiki sakharnogo diabeta 1 tipa
Kuraeva T.L., Titovich E.V., Peterkova V.A.
Type 2 diabetes and metabolic syndrome: identification of the molecular mechanisms, key signaling pathways and transcription factors aimed to reveal new therapeutical targets
Dedov I.I., Tkachuk V.A., Gusev N.B., Shirinsky V.P., Vorotnikov A.V., Kochegura T.N., Mayorov A.Y., Shestakova M.V.
Rol' bazal'nogo insulina v lecheniisakharnogo diabeta 2 tipa
Antsiferov M.B., Petraneva E.V.
Opyt primeneniya Lantusa (glargin) u detey i podrostkov s sakharnym diabetom 1 tipa v klinicheskoy praktike
Petryaykina E.E., Dukhareva O.V., Rybkina O.G., Mandzhieva E.T., Mikhaylova T.D., Pronina E.A., Petryaykin A.V., Pashintseva L.P.
Glycemia control and glucose-lowering therapy in patients with type 2 diabetes mellitus and cardiovascular disease (review of multicenter randomized trials)
Kakorin S.V., Iskandaryan R.A., Mkrtumyan A.M.
Mozhno li dostignut' effektivnogo glikemicheskogo kontrolya sakharnogo diabeta 2 tipa: preimushchestva rannego naznacheniya insulina
Biryukova E.V.
Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
Klimontov V.V., Myakina N.E.
Osnovnye printsipy terapii sakharnogo diabeta 2 tipa
Dedov I.I., Demidova I.Y.
Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
Klimontov V.V.
Mestnaya allergicheskaya reaktsiya na chelovecheskiy insulin
Podgrebel'nyy A.N., Gorelysheva V.A., Smirnova O.M.
Issledovanie effektivnosti i bezopasnosti primeneniya pervogo bespikovogo analoga chelovecheskogo insulina dlitel'nogo deystviya lantus (glargin) u detey i podrostkov
Peterkova V.A., Kuraeva T.L., Andrianova E.A., Shcherbacheva L.N., Maksimova V.P., Prokof'ev S.A., Titovich E.V.
Novye vozmozhnosti insulinoterapii sakharnogo diabeta u detey i podrostkov
Kuraeva T.L., Emel'yanov A.O., Eremina I.A., Peterkova V.A.
Insulin degludec is a new ultra-long-acting insulin analogue
Dedov I.I., Shestakova M.V.
Kharakteristika fazy remissii pri vpervye vyyavlennom insulinzavisimom sakharnom diabete
Smirnova O.M., Gorelysheva V.A., Dedov I.I.
Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
Klimontov V.V., Lazarev M.M., Makhotin A.A., Letyagin A.J., Anisimova L.A., Bulumbaeva D.M., Koroleva E.A., Lykov A.P.
Lantus (insulin glargin): real'nye preimushchestva i perspektivy primeneniya v pediatrii
Peterkova V.A., Kuraeva T.L., Titovich E.V.
Leptin secretion and severity of glycemic disorders in women with body weight excess
Dreval' A.V., Trigolosova I.V., Misnikova I.V.
Intraperitoneal insulin infusion: on the way to the artificial pancreas
Karpel'ev V.A., Fedorova E.A., Philippov Y.I., Mayorov A.Y., Shestakova M.V.
Sekretsiya insulina v normei pri sakharnom diabete 2 tipa
Ametov A.S.
Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
Kuraeva T.L.
Risk of oncological diseases in patients with diabetes mellitus
Galstyan G.R.
Increased apoptosis, but not pancreatic duodenal homeobox-1 expression in pancreatic islets is associated with intermittent glucose loads in mice
Herawati L., Wigati K., Rejeki P., Widjiati W., Irawan R.
Dvukhfaznyy insulin aspart 30 plyusmetformin: effektivnaya kombinatsiyadlya lecheniya sakharnogo diabeta 2 tipa
Kvapil M., Svatko A., Khilberg K., Shestakova M.V.
Melatonin and diabetes: from pathophysiology to the treatment perspectives
Konenkov V.I., Klimontov V.V., Michurina S.V., Prudnikova M.A., Ishenko I.J.
Pharmacoepidemiological and pharmacoeconomic analyses of the utilization of hypoglycaemic drugs in patients with type 2 diabetes mellitus in Moscow
Kalashnikova M.F., Belousov D.Y., Suntsov Y.I., Kantemirova M.A., Dedov I.I.
Kriterii diagnoza sakharnogo diabeta i prognoz glyukoznoy intolerantnosti
Strongin L.G.
Insulin glargin v lechenii sakharnogo diabeta 2 tipa: dokazatel'naya otsenka ego klinicheskoy i ekonomicheskoy effektivnosti
Glinkina I.V.
Lypohypertrophy in patients receiving insulin therapy: state of the art
Volkova N.I., Davidenko I.Y.
Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia
Sozaeva L.S., Zilberman L.I., Svetlova G.N., Andrianova E.A., Kareva M.A., Ivanova O.N., Stepanova S.M., Savelyeva L.V., Mayorov A.Y., Troshina E.A., Orlova E.M., Husebye E.S., Peterkova V.A.
Type 2 diabetes mellitus: time to change the concept
Levit S., Filippov Y.I., Gorelyshev A.S.
Type 2 diabetes therapeutic strategies: why don't we see the «ELEPHANT» in the room?
Levit S., Giveon S., Philippov Y.I., Panchev Domuschiev I., Zivony A.
Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
Klimontov V.V., Tsiberkin A.I., Fazullina O.N., Prudnikova M.A., Tyan N.V., Konenkov V.I.
Prospects of antigen-specific therapy in type 1 diabetes mellitus
Nikonova T.V., Alekseeva Y.V.
When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
Buryukova E.V., Jabbar A., Elizarova S.V.
Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study
Biryukova E.V., Ametov A.S., Antsiferov M.B., Zalevskaya A.G., Mel'nichenko G.A., Mkrtumyan A.M., Shestakova M.V.
1 - 76 of 76 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies